Makoto is an infectious disease physician and a clinical epidemiologist. Since joining WWARN/IDDO in 2015, he has worked on malaria in pregnancy, supporting the 2022 revision of the WHO malaria treatment guidelines to recommend artemether-lumefantrine for women in their first trimester.
His research interests extend broadly to the epidemiology of clinical infectious diseases, including nosocomial bacterial infections and antimicrobial resistance (AMR). Currently, his research focuses on evidence synthesis related to AMR, particularly in low- and middle-income countries, to support evidence-based actions against AMR where data is limited.
He completed his DPhil at the Nuffield Department of Medicine, Oxford (2015-2019, Clarendon Scholar, NDM Graduate Prize 2019). He earned an MD from the University of Tokyo, as well as an MSc in Tropical Medicine and International Health and an MSc in Epidemiology from the London School of Hygiene and Tropical Medicine. He is a certified epidemiologist and infectious disease specialist in Japan and a fellow of the Japanese Society of Internal Medicine. He is a Wolfson College Research Fellow in Sciences.